Castiglione-Gertsch M - Search Results

1

Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).

Bernhard J, Hürny C, Coates AS, Peterson HF, Castiglione-Gertsch M, Gelber RD, Galligioni E, Marini G, Thürlimann B, Forbes JF, Goldhirsch A, Senn HJ, Rudenstam CM. Bernhard J, et al. Br J Cancer. 1998 Sep;78(5):686-93. doi: 10.1038/bjc.1998.561. Br J Cancer. 1998. PMID: 9744512 Free PMC article.

2

Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.

Bernhard J, Hürny C, Coates AS, Peterson HF, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Senn HJ, Rudenstam CM. Bernhard J, et al. Ann Oncol. 1997 Sep;8(9):825-35. doi: 10.1023/a:1008269715091. Ann Oncol. 1997. PMID: 9358933 Free article. Clinical Trial.

3

Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.

Colleoni M, Price K, Castiglione-Gertsch M, Goldhirsch A, Coates A, Lindtner J, Collins J, Gelber RD, Thürlimann B, Rudenstam CM. Colleoni M, et al. Eur J Cancer. 1998 Oct;34(11):1693-700. doi: 10.1016/s0959-8049(98)00209-3. Eur J Cancer. 1998. PMID: 9893654

4

Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.

Colleoni M, Litman HJ, Castiglione-Gertsch M, Sauerbrei W, Gelber RD, Bonetti M, Coates AS, Schumacher M, Bastert G, Rudenstam CM, Schmoor C, Lindtner J, Collins J, Thürlimann B, Holmberg SB, Crivellari D, Beyerle C, Neumann RL, Goldhirsch A; International Breast Cancer Study Group; German Breast Cancer Study Group. Colleoni M, et al. Br J Cancer. 2002 Jun 5;86(11):1705-14. doi: 10.1038/sj.bjc.6600334. Br J Cancer. 2002. PMID: 12087454 Free PMC article. Clinical Trial.

5

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer.

Bernhard J, Zahrieh D, Coates AS, Gelber RD, Castiglione-Gertsch M, Murray E, Forbes JF, Perey L, Collins J, Snyder R, Rudenstam CM, Crivellari D, Veronesi A, Thürlimann B, Fey MF, Price KN, Goldhirsch A, Hürny C. Bernhard J, et al. Br J Cancer. 2004 Nov 29;91(11):1893-901. doi: 10.1038/sj.bjc.6602230. Br J Cancer. 2004. PMID: 15545973 Free PMC article. Clinical Trial.

6

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

Bernhard J, Zahrieh D, Zhang JJ, Martinelli G, Basser R, Hürny C, Forbes JF, Aebi S, Yeo W, Thürlimann B, Green MD, Colleoni M, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS; International Breast Cancer Study Group. Bernhard J, et al. Br J Cancer. 2008 Jan 15;98(1):25-33. doi: 10.1038/sj.bjc.6604092. Epub 2007 Nov 27. Br J Cancer. 2008. PMID: 18043579 Free PMC article. Clinical Trial.

7

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.

Hürny C, Bernhard J, Coates AS, Castiglione-Gertsch M, Peterson HF, Gelber RD, Forbes JF, Rudenstam CM, Simoncini E, Crivellari D, Goldhirsch A, Senn HJ. Hürny C, et al. Lancet. 1996 May 11;347(9011):1279-84. doi: 10.1016/s0140-6736(96)90936-8. Lancet. 1996. PMID: 8622502 Clinical Trial.

8

Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.

Hürny C, Bernhard J, Coates A, Peterson HF, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Collins J, Lindtner J, Goldhirsch A, Senn HJ. Hürny C, et al. Med Care. 1996 Mar;34(3):234-48. doi: 10.1097/00005650-199603000-00004. Med Care. 1996. PMID: 8628043 Clinical Trial.

9

Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.

Bernhard J, Peterson HF, Coates AS, Gusset H, Isley M, Hinkle R, Gelber RD, Castiglione-Gertsch M, Hürny C. Bernhard J, et al. Stat Med. 1998 Mar 15-Apr 15;17(5-7):587-601. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<587::aid-sim806>3.0.co;2-#. Stat Med. 1998. PMID: 9549808

10

Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.

Castiglione-Gertsch M, Tattersall M, Hacking A, Goldhirsch A, Gudgeon A, Gelber RD, Lindtner J, Coates A, Collins J, Isley M, Senn HJ, Rudenstam CM. Castiglione-Gertsch M, et al. Eur J Cancer. 1997 Dec;33(14):2321-5. doi: 10.1016/s0959-8049(97)10011-9. Eur J Cancer. 1997. PMID: 9616275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters